Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen <it>Plasmodium falciparum</it> FVO merozoite surface protein-1 (MSP1<sub>42</sub>) administered intramuscularly with adjuvant system AS01
<p>Abstract</p> <p>Background</p> <p>The development of an asexual blood stage vaccine against <it>Plasmodium falciparum</it> malaria based on the major merozoite surface protein-1 (MSP1) antigen is founded on the protective efficacy observed in preclinical studies and induction of invasion and grow...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2013-01-01
|
| coleção: | Malaria Journal |
| Assuntos: | |
| Acesso em linha: | http://www.malariajournal.com/content/12/1/29 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
